The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer
Article in International Journal of Technology Assessment in Health Care (March 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in International Journal of Technology Assessment in Health Care (March 2024)
Article in Patient Preference and Adherence (August 2023)
Article in Journal of Medical Economics (April 2023)